• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 87 of 100
Pfizer In Merger Talks With Allergan PLC
HealthPfizer, Allergan Confirm $160 Billion Merger Deal
By Geoffrey Smith and Claire GrodenNovember 23, 2015
Pfizer In Merger Talks With Allergan PLC
LeadershipPfizer, Allergan Poised for $150 Billion Merger
By Claire GrodenNovember 22, 2015
The Powerful And Influential Attend Clinton Global Initiative Annual Meeting
HealthMerck CEO Blasts Company that Raised Drug Prices 5,000%
By Laura LorenzettiNovember 20, 2015
BRITAIN-PHARMA-BUSINESS-ASTRAZENECA
HealthAstraZeneca, Sanofi Add New Twist to Pharma Merger Mania
By Reuters and Fortune EditorsNovember 20, 2015
MSMB Capital Management CIO Martin Shkreli
FinanceTuring CEO Invested in This Penny Stock Biotech to Keep It Alive
By Laura LorenzettiNovember 19, 2015
Pfizer And AstraZeneca's Billion Dollar Battle
LeadershipA Pfizer Deal With Allergan Would Add Fuel to the Fight Over Taxes
By Alan MurrayNovember 19, 2015
Mylan Buys Abbott Laboratories Generic Drug Business For $5.3 Billion
LeadershipThe Treasury Will Crack Down on ‘Tax Inversions’ This Week
By Geoffrey SmithNovember 19, 2015
571977919
HealthGlobal Drug Spending Will Reach $1.4 Trillion by 2020
By Laura LorenzettiNovember 18, 2015
Police Operation in Saint Denis
TechParis Siege and Square Prices IPO–5 Things to Know Today
By Laura Lorenzetti and Geoffrey SmithNovember 18, 2015
Flibanserin
HealthWhy ‘Female Viagra’ Is Not Selling
By Robert HackettNovember 17, 2015
14th Annual Elton John AIDS Foundation An Enduring Vision Benefit - Show
FinanceWhy Mylan Just Lost The Largest Hostile Takeover Battle Ever
By Jen WiecznerNovember 13, 2015
Mylan Buys Abbott Laboratories Generic Drug Business For $5.3 Billion
LeadershipMylan, Valeant and Theranos: What the Heck, Biotech?
By Jeffrey SonnenfeldNovember 13, 2015
Mylan Buys Abbott Laboratories Generic Drug Business For $5.3 Billion
HealthMylan’s Hostile Bid for Perrigo Fails
By ReutersNovember 13, 2015
Bill Ackman
HealthValeant, Ackman Must Face U.S. Insider Trading Lawsuit
By ReutersNovember 11, 2015
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
FinanceValeant CEO Defends Firm but Says He Doesn’t Have ‘Full Knowledge’
By Stephen GandelNovember 10, 2015
1...
  • 85
  • 86
  • 87
  • 88
  • 89
...100
Most Popular
Future of Work
'Employers are increasingly turning to degree and GPA' in hiring: Recruiters retreat from ‘talent is everywhere,’ double down on top collegesplaceholder alt text
By Jake AngeloMay 9, 2026
Politics
Ted Cruz says the quiet part out loud: Trump accounts are Social Security personal accounts as GOP senator reveals 'dirty little secret'placeholder alt text
By Jason MaMay 9, 2026
Success
Red flag test: former CEO explains why he rejects job candidates who say they can start right awayplaceholder alt text
By Orianna Rosa RoyleMay 9, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.